title: Bettering BCG: a tough task for a TB vaccine?
authors.affiliation: KwaZulu-Natal Research Institute for Tuberculosis and HIV, Durban, South Africa and Johns Hopkins University, Baltimore, Maryland, USA.
authors.forename: William
authors.initials: W
authors.lastname: Bishai
authors.forename: Zuri
authors.initials: Z
authors.lastname: Sullivan
authors.forename: Barry R
authors.initials: BR
authors.lastname: Bloom
authors.forename: Peter
authors.initials: P
authors.lastname: Andersen
mesh_terms: D001500:BCG Vaccine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D007223:Infant; D032581:Tuberculosis Vaccines / Q000009:adverse effects / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000517:prevention & control*; D019444:Vaccines, DNA; D014765:Viral Vaccines / Q000627:therapeutic use
chemical_list: D001500:BCG Vaccine; C549320:MVA 85A; D032581:Tuberculosis Vaccines; D019444:Vaccines, DNA; D014765:Viral Vaccines
references.citation: Lancet. 2013 Mar 23;381(9871):1021-8
references.pmid: 23391465
references.citation: Nature. 2010 Aug 19;466(7309):973-7
references.pmid: 20725040
references.citation: Science. 2013 Mar 22;339(6126):1448-53
references.pmid: 23449998
references.citation: PLoS One. 2012;7(6):e39909
references.pmid: 22768165
references.citation: J Infect Dis. 2011 Jun 15;203(12):1832-43
references.pmid: 21606542
references.citation: PLoS One. 2009;4(4):e5264
references.pmid: 19367339
references.citation: Science. 2006 Mar 24;311(5768):1770-3
references.pmid: 16497887
references.citation: Science. 2001 Feb 23;291(5508):1544-7
references.pmid: 11222859
references.citation: Am J Epidemiol. 2013 Mar 15;177(6):556-61
references.pmid: 23423215